The TNF-alpha inhibitor is indicated to treat children weighing at least 15 kg living with moderately to severely active ulcerative colitis.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/fda-oks-simponi-pediatric-ulcerative-colitis-2025a1000r5u?src=rss
Author :
Publish date : 2025-10-08 16:02:00
Copyright for syndicated content belongs to the linked Source.
